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Background/introduction
This study investigated whether targeted delivery of the
inhibitory neurotransmitter gamma-Aminobutyric acid
(GABA), a small molecule (103 Da) that normally does
not reach the brain with systemic administration, can
temporarily block brain activity after ultrasound-induced
blood-brain barrier (BBB) disruption.
Methods
Focused ultrasound exposures (10 ms bursts applied at 1
Hz for 60 s; pressure amplitude in water: 0.64-0.71
MPa) were delivered immediately after the administra-
tion of Definity microbubbles (20 or 40 μl/kg) to disrupt
the BBB. The focal point was targeted to 10 overlapping
targets on and around the somatosensory motor cortex
(2 mm lateral, 2 mm posterior to bregma) under MRI
guidance in 5 rats. BBB disruption was confirmed using
Gd-DTPA MRI contrast agent (Magnevist, 0.25 ml/kg).
After the sonications, electrodes were implanted into
the thigh muscle to electrically stimulate the sciatic
nerve (stimulation voltage: 9-20 V). Somatosensory
evoked potentials (SSEP) were recorded transcranially
before and after intravenous GABA at doses ranging
from 0.8 to 519 mg/kg. The SSEP recordings were
repeated in two animals at 24h after sonication and one
animal at 5 days. SSEP measurements were obtained in
two control animals who received GABA but not ultra-
sound-induced BBB disruption.
Results and conclusions
The amplitude of the SSEP recordings in the animals who
received GABA and ultrasound-induced BBB disruption
were reduced by 6-94%. There was a good correlation (R²:
0.79) between the percent suppression in SSEP magnitude
and GABA dose. This suppression also correlated with the
degree of BBB disruption – for similar GABA doses, ani-
mals that had less suppression also had weaker enhance-
ment in MRI after Gd-DTPA administration. For relatively
small doses of GABA (0.8-64 mg/kg), the duration of the
suppression lasted between 2-20 min, with higher doses
resulting in longer durations. At high doses (422 mg/kg
and above) the suppression lasted the length of the record-
ings (up to 100 min). No suppression was observed after
GABA administration in control animals or in recordings
performed 24h or 5d after the sonications. This work
demonstrates an alternative ultrasound-based method to
block neuronal function. It has some advantages over
other ultrasound “neuromodulation” techniques: the
ability to use contrast MRI to definitively confirm where
the suppression is targeted, the ability to titrate the GABA
dose to control the level of suppression, and the ability to
recover the animal from anesthesia and transiently block
function in a freely behaving animal. Since the effects of
GABA and other neurotransmitters have been studied for
decades, the mechanisms of the suppression are well
understood. We anticipate that the use of GABA and
other neurotransmitters in this way can be useful for
noninvasively mapping brain function and potentially for
surgical planning or novel therapies.
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